Skip to main content
. 2011 Dec 28;97(3):E496–E502. doi: 10.1210/jc.2011-2220

Table 1.

Clinical manifestations of CNC in patients that carried PRKAR1A mutations abolishing the normal stop codon

Patient ID Age (yr) Gender Manifestations (age of first diagnosis)
Manifestations (age of first diagnosis)
Mutation
Cardiac myxomas Breast myxomas Lentigenosis Other skin lesions Acromegaly Cushing's syndrome LCCSCT Thyroid tumors Ovarian tumors Schwannomas cDNA Protein
CAR15.02 50 F + (27) + (27) + + + (32) + (32) + (32) c.1076_77delTTins13 p.Leu359fsPLUS62
CAR15.04 14 M + + + (4) + (4) c.1076_77delTTins13 p.Leu359fsPLUS62
CAR66.03 19 F + + + + + (13) + (19) c.1055_1058delGACC p.Arg352fsPLUS57
CAR540.01 63 M + (33) + (33) + + + (41) + (25) c1067_1070delAACGins5 p.Glu356fsPLUS45
CAR540.11 27 M + + + (24) c1067_1070delAACGins5 p.Glu356fsPLUS45
CAR541.01 6 M + + c1142_1145delTCTG p.Val381fsPLUS58
CAR541.05 26 M + + c1142_1145delTCTG p.Val381fsPLUS58

The age of diagnosis of the respective tumor is indicated in parentheses (when this information was available). Patients CAR15.02 and CAR66.03 had multiple cardiac myxomas and schwannomas, respectively. F, Female; LCCSCT, large-cell calcifying Sertoli cell tumor; M, male.